Cesarman, Ethel

Publications

Sort by

Co-Author Network

selected publications

Locus specific human endogenous retroviruses reveal new lymphoma subtypes. bioRxiv : the preprint server for biology. 2023 Article GET IT
Times cited: 3855
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells. Blood cancer discovery. 2023 Academic Article GET IT
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib. 2023 GET IT
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 Academic Article GET IT
Times cited: 7
LAMP-enabled diagnosis of Kaposi's sarcoma for sub-Saharan Africa. Science advances. 2023 Academic Article GET IT
Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma. Blood advances. 2022 Academic Article GET IT
Times cited: 2
Author Correction: DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression. Nature microbiology. 2022 Article GET IT
3D chromosomal architecture in germinal center B cells and its alterations in lymphomagenesis. Current opinion in genetics & development. 2022 Review GET IT
KSHV/HHV8-mediated hematologic diseases. Blood. 2022 Review GET IT
Times cited: 18
Latent Membrane Protein 1 (LMP1) from Epstein-Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells. Genes. 2022 Academic Article GET IT
Times cited: 1
Kaposi's sarcoma herpesvirus activates the hypoxia response to usurp HIF2α-dependent translation initiation for replication and oncogenesis. Cell reports. 2021 Academic Article GET IT
Times cited: 4
Histone H1 Mutations in Lymphoma: A Link(er) between Chromatin Organization, Developmental Reprogramming, and Cancer. Cancer research. 2021 Review GET IT
Times cited: 5
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma. Haematologica. 2021 Academic Article GET IT
Times cited: 6
Retraction: KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells. The Journal of experimental medicine. 2021 Academic Article GET IT
H1 histones control the epigenetic landscape by local chromatin compaction. Nature. 2020 Academic Article GET IT
Times cited: 60
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature. 2020 Academic Article GET IT
Times cited: 95
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes. Blood advances. 2020 Academic Article GET IT
Times cited: 20
KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. PLoS pathogens. 2020 Academic Article GET IT
Times cited: 6
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020 Academic Article GET IT
Times cited: 27
Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study. JCO global oncology. 2020 Academic Article GET IT
Times cited: 2
Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers. JCO global oncology. 2020 Academic Article GET IT
Times cited: 10
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy. Blood. 2020 Academic Article GET IT
Times cited: 31
DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression. Nature microbiology. 2020 Academic Article GET IT
Times cited: 19
Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics. Nature communications. 2020 Academic Article GET IT
Times cited: 21
Viral FLIP blocks Caspase-8 driven apoptosis in the gut in vivo. PloS one. 2020 Academic Article GET IT
Times cited: 4
Kaposi sarcoma. Nature reviews. Disease primers. 2019 Review GET IT
Times cited: 245
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas. Blood advances. 2018 Academic Article GET IT
Times cited: 8
A portable device for nucleic acid quantification powered by sunlight, a flame or electricity. Nature biomedical engineering. 2018 Academic Article GET IT
Times cited: 49
Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells. Mucosal immunology. 2018 Academic Article GET IT
Times cited: 6
Mast Cell Activation and KSHV Infection in Kaposi Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 13
KSHV induces immunoglobulin rearrangements in mature B lymphocytes. PLoS pathogens. 2018 Academic Article GET IT
Times cited: 26
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clinical lymphoma, myeloma & leukemia. 2018 Academic Article GET IT
Times cited: 10
Editorial overview: Viruses and cancer: How tumor viruses affect the cellular genome. Current opinion in virology. 2017 Editorial Article GET IT
Times cited: 1
Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression. Cell host & microbe. 2017 Academic Article GET IT
Times cited: 88
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma. Molecular cancer therapeutics. 2017 Academic Article GET IT
Times cited: 47
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma. Journal of visualized experiments : JoVE. 2017 Academic Article GET IT
Times cited: 5
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies. The Journal of clinical investigation. 2017 Academic Article GET IT
Times cited: 6
The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016 Academic Article GET IT
Times cited: 167
Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?. Current opinion in virology. 2016 Review GET IT
Times cited: 26
KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples. PloS one. 2016 Academic Article GET IT
Times cited: 26
Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis. Current opinion in virology. 2015 Review GET IT
Times cited: 94
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 2015 Academic Article GET IT
Times cited: 66
The tumor virus landscape of AIDS-related lymphomas. Blood. 2015 Academic Article GET IT
Times cited: 54
Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo. PLoS pathogens. 2015 Academic Article GET IT
Times cited: 30
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2014 Academic Article GET IT
Times cited: 237
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. The Journal of clinical investigation. 2014 Academic Article GET IT
Times cited: 54
Detection of Kaposi's sarcoma associated herpesvirus nucleic acids using a smartphone accessory. Lab on a chip. 2014 Academic Article GET IT
Times cited: 40
FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. Blood. 2014 Academic Article GET IT
Times cited: 26
How do viruses trick B cells into becoming lymphomas?. Current opinion in hematology. 2014 Review GET IT
Times cited: 13
Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics. Scientific reports. 2014 Academic Article GET IT
Times cited: 94
KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell cycle (Georgetown, Tex.). 2014 Academic Article GET IT
Times cited: 12
Gammaherpesviruses and lymphoproliferative disorders. Annual review of pathology. 2013 Review GET IT
Times cited: 146
Pathology of lymphoma in HIV. Current opinion in oncology. 2013 Review GET IT
Times cited: 41
The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1. Journal of virology. 2013 Academic Article GET IT
Times cited: 10
Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies. Blood. 2013 Academic Article GET IT
Times cited: 59
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. 2013 GET IT
Times cited: 102
Multiplexed colorimetric detection of Kaposi's sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles. Nanoscale. 2013 Academic Article GET IT
Times cited: 74
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 21
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood. 2012 Academic Article GET IT
Times cited: 82
Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. British journal of haematology. 2012 Academic Article GET IT
Times cited: 36
Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. Journal of acquired immune deficiency syndromes (1999). 2012 Academic Article GET IT
Times cited: 51
Viral lymphomas: can antivirals be used to treat cancer?. Hematology (Amsterdam, Netherlands). 2012 Academic Article GET IT
Times cited: 2
Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D. Cell host & microbe. 2011 Comment GET IT
Times cited: 6
Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma. The Journal of infectious diseases. 2011 Academic Article GET IT
Times cited: 34
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer letters. 2011 Review GET IT
Times cited: 139
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood. 2011 Academic Article GET IT
Times cited: 28
Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. The Journal of clinical investigation. 2011 Academic Article GET IT
Times cited: 79
NF-κB as a target for oncogenic viruses. Current topics in microbiology and immunology. 2011 Review GET IT
Times cited: 38
Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. Journal of acquired immune deficiency syndromes (1999). 2011 Academic Article GET IT
Times cited: 43
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 278
Kaposi's sarcoma and its associated herpesvirus. Nature reviews. Cancer. 2010 Review GET IT
Times cited: 602
Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration. The Journal of pathology. 2010 Academic Article GET IT
Times cited: 51
NF-kappaB signaling modulation by EBV and KSHV. Trends in microbiology. 2010 Review GET IT
Times cited: 105
Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. AIDS (London, England). 2010 Editorial Article GET IT
Times cited: 40
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2009 Academic Article GET IT
Times cited: 199
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 77
Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 2009 Academic Article GET IT
Times cited: 96
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma. Journal of virology. 2009 Academic Article GET IT
Times cited: 11
Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome. American journal of clinical pathology. 2008 Academic Article GET IT
Times cited: 5
Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma. Leukemia. 2008 Letter GET IT
Times cited: 17
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD). Histopathology. 2008 Academic Article GET IT
Times cited: 65
The pathobiology of Kaposi's sarcoma: advances since the onset of the AIDS epidemic. Journal of cutaneous pathology. 2008 Review GET IT
Times cited: 25
HIV-associated lymphomas and gamma-herpesviruses. Blood. 2008 Review GET IT
Times cited: 268
Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma. British journal of haematology. 2008 Academic Article GET IT
Times cited: 43
Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer. 2008 Academic Article GET IT
Times cited: 11
EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood. 2008 Academic Article GET IT
Times cited: 73
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood. 2008 Academic Article GET IT
Times cited: 96
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen. Oncogene. 2007 Academic Article GET IT
Times cited: 99
Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Current topics in microbiology and immunology. 2007 Review GET IT
Times cited: 55
Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda. 2006 GET IT
Times cited: 15
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood. 2006 Academic Article GET IT
Times cited: 166
beta-Glucuronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia. The Journal of molecular diagnostics : JMD. 2006 Academic Article GET IT
Times cited: 14
Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts. The Journal of molecular diagnostics : JMD. 2006 Academic Article GET IT
Times cited: 27
Pathogenesis of viral lymphomas. Cancer treatment and research. 2006 Review GET IT
Times cited: 11
The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO reports. 2006 Academic Article GET IT
Times cited: 72
NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood. 2005 Academic Article GET IT
Times cited: 144
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood. 2005 Academic Article GET IT
Times cited: 40
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 145
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 2005 Academic Article GET IT
Times cited: 349
Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA. Journal of virology. 2005 Academic Article GET IT
Times cited: 29
Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. Journal of virology. 2005 Academic Article GET IT
Times cited: 110
KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. The American journal of surgical pathology. 2004 Academic Article GET IT
Times cited: 256
Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysis. Genome biology. 2004 Review GET IT
Times cited: 9
KSHV vFLIP is essential for the survival of infected lymphoma cells. The Journal of experimental medicine. 2004 Academic Article GET IT
Times cited: 286
The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene. 2004 Academic Article GET IT
Times cited: 67
Kaposi's sarcoma-associated herpesvirus--the high cost of viral survival. The New England journal of medicine. 2003 Comment GET IT
Times cited: 13
Pathogenesis of Kaposi's sarcoma. Hematology/oncology clinics of North America. 2003 Review GET IT
Times cited: 43
Alterations of mRNA splicing in primary effusion lymphomas. Leukemia & lymphoma. 2003 Academic Article GET IT
Times cited: 4
Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. The American journal of surgical pathology. 2003 Academic Article GET IT
Times cited: 52
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 2003 Academic Article GET IT
Times cited: 225
The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. Journal of virology. 2003 Academic Article GET IT
Times cited: 109
Human herpesvirus-8-associated lymphoma of the bowel in human immunodeficiency virus-positive patients without history of primary effusion lymphoma. 2002 GET IT
Times cited: 48
Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clinical microbiology reviews. 2002 Review GET IT
Times cited: 256
Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication. Journal of virology. 2002 Academic Article GET IT
Times cited: 24
Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. American journal of clinical pathology. 2002 Academic Article GET IT
Times cited: 42
Epstein-Barr virus (EBV) and lymphomagenesis. Frontiers in bioscience : a journal and virtual library. 2002 Review GET IT
Times cited: 23
Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. The American journal of pathology. 2002 Academic Article GET IT
Times cited: 75
The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 2002 Review GET IT
Times cited: 49
Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood. 2001 Academic Article GET IT
Times cited: 155
Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas. Virology. 2001 Academic Article GET IT
Times cited: 45
Detection and characterization of human herpesvirus-8-infected cells in bone marrow biopsies of human immunodeficiency virus-positive patients. Human pathology. 2001 Academic Article GET IT
Times cited: 13
Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. Journal of virology. 2001 Academic Article GET IT
Times cited: 60
Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. The Journal of molecular diagnostics : JMD. 2001 Academic Article GET IT
Times cited: 64
BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood. 2001 Academic Article GET IT
Times cited: 39
Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease. Human pathology. 2001 Academic Article GET IT
Times cited: 66
Molecular Detection of Kaposi's Sarcoma-Associated Herpesvirus/ Human Herpesvirus-8. Methods in molecular medicine. 2001 Academic Article GET IT
Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood. 2000 Academic Article GET IT
Times cited: 294
Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy. Seminars in oncology. 2000 Review GET IT
Times cited: 31
Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer. 2000 Academic Article GET IT
Times cited: 29
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?. The Journal of experimental medicine. 2000 Comment GET IT
Times cited: 132
Aggressive natural killer cell lymphoma presenting as an anterior mediastinal mass in a patient with acquired immunodeficiency syndrome. 2000 GET IT
Times cited: 5
Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. The Journal of infectious diseases. 1999 Academic Article GET IT
Times cited: 109
Virus-associated lymphomas. Current opinion in oncology. 1999 Review GET IT
Times cited: 30
A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma. 1999 GET IT
Times cited: 45
The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Seminars in cancer biology. 1999 Review GET IT
Times cited: 162
Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. 1999 GET IT
Times cited: 71
Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. The American journal of pathology. 1998 Academic Article GET IT
Times cited: 146
BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood. 1998 Academic Article GET IT
Times cited: 131
Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature. 1998 Academic Article GET IT
Times cited: 354
Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood. 1998 Academic Article GET IT
Times cited: 78
The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer. 1998 Academic Article GET IT
Times cited: 112
HIV/AIDS case histories: diagnostic problems. Primary effusion lymphoma. 1998 GET IT
Times cited: 1
Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture. The Journal of experimental medicine. 1998 Academic Article GET IT
Times cited: 70
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 1998 Academic Article GET IT
Times cited: 753
Cyclin D1 and retinoblastoma protein expression in Kaposi's sarcoma. Journal of cutaneous pathology. 1997 Academic Article GET IT
Times cited: 21
Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. The American journal of pathology. 1997 Academic Article GET IT
Times cited: 29
Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer. 1997 Academic Article GET IT
Times cited: 75
Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood. 1997 Academic Article GET IT
Times cited: 181
Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. 1997 GET IT
Times cited: 111
Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Seminars in diagnostic pathology. 1997 Review GET IT
Times cited: 145
Molecular pathology of posttransplantation lymphoproliferative disorders. Seminars in diagnostic pathology. 1997 Conference Paper GET IT
Times cited: 111
Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature. 1997 Academic Article GET IT
Times cited: 577
The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases. Annals of oncology : official journal of the European Society for Medical Oncology. 1997 Review GET IT
Times cited: 35
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. Journal of virology. 1996 Academic Article GET IT
Times cited: 351
Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. 1996 GET IT
Times cited: 221
Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood. 1996 Academic Article GET IT
Times cited: 355
Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996 Academic Article GET IT
Times cited: 962
Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. The American journal of pathology. 1996 Academic Article GET IT
Times cited: 202
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood. 1996 Academic Article GET IT
Times cited: 167
Molecular characterization of primary mediastinal B cell lymphoma. The American journal of pathology. 1996 Academic Article GET IT
Times cited: 74
Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. The Journal of experimental medicine. 1996 Academic Article GET IT
Times cited: 217
Absence of Kaposi's-sarcoma-associated herpesvirus-like DNA sequences (KSHV) in angiosarcomas developing in body-cavity and other sites. International journal of cancer. 1996 Letter GET IT
Times cited: 16
Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. The New England journal of medicine. 1996 Letter GET IT
Times cited: 63
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. Journal of virology. 1996 Academic Article GET IT
Times cited: 525
Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. The American journal of pathology. 1995 Academic Article GET IT
Times cited: 72
Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. The New England journal of medicine. 1995 Letter GET IT
Times cited: 146
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 1995 Academic Article GET IT
Times cited: 518
Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. 1995 GET IT
Times cited: 38
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. The New England journal of medicine. 1995 Academic Article GET IT
Times cited: 2517
Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood. 1995 Academic Article GET IT
Times cited: 108
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995 Academic Article GET IT
Times cited: 546
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (New York, N.Y.). 1994 Academic Article GET IT
Times cited: 5022
Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood. 1994 Academic Article GET IT
Times cited: 62
Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. The American journal of pathology. 1994 Academic Article GET IT
Times cited: 68
The MDM2 oncogene is rarely amplified in human lymphoid tumors and does not correlate with p53 gene expression. International journal of cancer. 1994 Letter GET IT
Times cited: 13
Prevention and treatment of traveler's diarrhea. The New England journal of medicine. 1993 Letter GET IT
Times cited: 8
CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer. 1993 Academic Article GET IT
Times cited: 130
High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. The American journal of pathology. 1993 Academic Article GET IT
Times cited: 118
Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction. Laboratory investigation; a journal of technical methods and pathology. 1993 Academic Article GET IT
Times cited: 102
Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood. 1992 Academic Article GET IT
Times cited: 114
Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science (New York, N.Y.). 1987 Academic Article GET IT
Times cited: 165
Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis. Annals of the New York Academy of Sciences. 1987 Review GET IT
Times cited: 17
Cellular oncogenes and the pathogenesis of human cancer. Horizons in biochemistry and biophysics. 1986 Review GET IT
Times cited: 2

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

B cell determinants of EBV latency awarded by National Cancer Institute Principal Investigator 2022 - 2027
Next-Gen Oncopathology Program awarded by National Cancer Institute Principal Investigator 2022 - 2027
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment awarded by National Cancer Institute Principal Investigator 2022 - 2025
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment awarded by National Cancer Institute Principal Investigator 2020 - 2025
Role of novel onco-histone mutations in B-cell malignancies awarded by National Cancer Institute Principal Investigator 2019 - 2024
Weill Cornell Initiative for Maximizing Student Development awarded by National Institute of General Medical Sciences Principal Investigator 2019 - 2024

Modulation Of Viral Latency In EBV+ Lymphomas To Sensitize Tumors To Immunotherapy awarded by American Society of Hematology Inc Co-Investigator 2021 - 2023
Role Of The Linker Histones H1 In Lymphomas awarded by American Association for Cancer Research Co-Investigator 2021 - 2023

Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID) awarded by National Institute of Allergy & Infectious Diseases Key Personnel 2023 - 2028
Targeting Unmet Needs For B-cell Lymphomas awarded by Leukemia & Lymphoma Society, Inc. Key Personnel 2022 - 2027
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma awarded by National Cancer Institute Key Personnel 2021 - 2026
Defining the evolution and tumor microenvironment interactions of classic Hodgkin lymphoma through single-cell multi-omics and genetically engineered mouse models awarded by Starr Cancer Consortium Key Personnel 2022 - 2023
Cohesin complex regulatory proteins and chromosomal architecture in normal and malignant B-cells awarded by American Society of Hematology Inc Key Personnel 2022 - 2023

Rapid Sample to Answer Diagnosis of Kaposi''s Sarcoma Across Sub-Saharan Africa using KS-COMPLETE awarded by National Institute of General Medical Sciences Principal Investigator Subaward 2022 - 2027
The AIDS Malignancy Consortium Grant (AMC) - Resource Lab awarded by National Cancer Institute Principal Investigator Subaward 2020 - 2023
The AIDS Malignancy Consortium Grant (AMC) - Scientific Working Group Payments awarded by National Cancer Institute Principal Investigator Subaward 2020 - 2023
Early Stage Diagnosis of Kaposi''s Sarcoma in Limited Resource Settings Using KS-Detect awarded by National Institute of General Medical Sciences Principal Investigator Subaward 2016 - 2023

more ...

less ...

Background

education and training

Ph.D., New York University 1988
M.S., New York University 1984
M.D., Autonomous Metropolitan University, Division of Biological Sciences and Health (Mexico) 1981

Contact

full name

Ethel Cesarman

primary email

ecesarm@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Ethel Cesarman Professor of Pathology and Laboratory Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage